Cargando…
Obesity and kidney protection
Context: Obesity, both directly and indirectly, increases the risk for a variety of disease conditions including diabetes, hypertension, liver disease, and certain cancers, which in turn, decreases the overall lifespan in both men and women. Though the cardiovascular risks of obesity are widely ackn...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Diabetic Nephropathy Prevention
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119329/ https://www.ncbi.nlm.nih.gov/pubmed/25093156 http://dx.doi.org/10.12860/jnp.2014.18 |
_version_ | 1782328949098938368 |
---|---|
author | Chandra, Aravind Biersmith, Michael Tolouian, Ramin |
author_facet | Chandra, Aravind Biersmith, Michael Tolouian, Ramin |
author_sort | Chandra, Aravind |
collection | PubMed |
description | Context: Obesity, both directly and indirectly, increases the risk for a variety of disease conditions including diabetes, hypertension, liver disease, and certain cancers, which in turn, decreases the overall lifespan in both men and women. Though the cardiovascular risks of obesity are widely acknowledged, less often identified is the relationship between obesity and renal function. Evidence Acquisitions: Directory of Open Access Journals (DOAJ), Google Scholar, PubMed, EBSCO and Web of Science has been searched. Results: The concept of the “Metabolic Syndrome“ helps us to understand this close link between obesity, diabetes, hypertension, and renal dysfunction. An elevated body mass index has shown to be one of the major determinants of glomerular hyperfiltration that lead to the development of chronic kidney disease. Interestingly, weight loss can lead to attenuation of hyperfiltration in severely obese patients suggesting a possible therapeutic option to combat obesity-related hyperfiltration. Conclusions: Various treatment strategies had been suggested to decrease impact of obesity on kidneys. These are blood pressure controling, inhibition of the renin-angiotensinaldosterone axis, improving glycemic control, improving dyslipidemia, improving protein uriaand lifestyle modifications. Regardless of the numerous pharmacotherapies, the focus should be on the root cause: obesity. |
format | Online Article Text |
id | pubmed-4119329 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Society of Diabetic Nephropathy Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-41193292014-08-04 Obesity and kidney protection Chandra, Aravind Biersmith, Michael Tolouian, Ramin J Nephropathol Short-Review Context: Obesity, both directly and indirectly, increases the risk for a variety of disease conditions including diabetes, hypertension, liver disease, and certain cancers, which in turn, decreases the overall lifespan in both men and women. Though the cardiovascular risks of obesity are widely acknowledged, less often identified is the relationship between obesity and renal function. Evidence Acquisitions: Directory of Open Access Journals (DOAJ), Google Scholar, PubMed, EBSCO and Web of Science has been searched. Results: The concept of the “Metabolic Syndrome“ helps us to understand this close link between obesity, diabetes, hypertension, and renal dysfunction. An elevated body mass index has shown to be one of the major determinants of glomerular hyperfiltration that lead to the development of chronic kidney disease. Interestingly, weight loss can lead to attenuation of hyperfiltration in severely obese patients suggesting a possible therapeutic option to combat obesity-related hyperfiltration. Conclusions: Various treatment strategies had been suggested to decrease impact of obesity on kidneys. These are blood pressure controling, inhibition of the renin-angiotensinaldosterone axis, improving glycemic control, improving dyslipidemia, improving protein uriaand lifestyle modifications. Regardless of the numerous pharmacotherapies, the focus should be on the root cause: obesity. Society of Diabetic Nephropathy Prevention 2014-07 2014-07-01 /pmc/articles/PMC4119329/ /pubmed/25093156 http://dx.doi.org/10.12860/jnp.2014.18 Text en © 2014 The Author(s) Published by Nickan Research Institute. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short-Review Chandra, Aravind Biersmith, Michael Tolouian, Ramin Obesity and kidney protection |
title | Obesity and kidney protection |
title_full | Obesity and kidney protection |
title_fullStr | Obesity and kidney protection |
title_full_unstemmed | Obesity and kidney protection |
title_short | Obesity and kidney protection |
title_sort | obesity and kidney protection |
topic | Short-Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119329/ https://www.ncbi.nlm.nih.gov/pubmed/25093156 http://dx.doi.org/10.12860/jnp.2014.18 |
work_keys_str_mv | AT chandraaravind obesityandkidneyprotection AT biersmithmichael obesityandkidneyprotection AT tolouianramin obesityandkidneyprotection |